For instance, ASCL1 serves as a pioneering NE lineage‐specific TF in both NEPC and SCLC,12, 15, 17 while ASCL2 produces the non‐NE lineage in lung cancer18 and the luminal lineage (non‐NE) in prostate cancer.15 This evidence concerns the gene ASCL1 and prostate carcinoma.